In May, we examined the possibility of Southeast Asian countries working together to create a regional COVID-19 Vaccination Certification (CVC) system. How far have Southeast Asian countries come in their CVC efforts? What form can certificates take and how can their authenticity be verified, given the limitations in infrastructure and capacity? Will mutual recognition of CVCs be possible when the type of vaccines and their doses differ significantly across countries in the region? We explore these questions, summarizing the discussions of a recent webinar on this very topic.
CGD Policy Blogs
Among the multilateral development banks, the Asian Development Bank (ADB) stands out for its strong financial support for COVID-19 response relative to its overall lending volume. While ADB has proven to be responsive to government’s general financing needs during the crisis, has ADB’s performance matched the specific needs of the governments and populations facing the crisis in the region? Have the greater volumes of support actually targeted the people, places, and sectors that most need it? In a new policy paper, we tackle these questions.
COVID-19 and the economic crisis it unleashed have spurred unprecedented action from governments and international institutions. Multilateral development banks (MDBs) like the Asian Development Bank (ADB) swiftly committed resources to COVID-19 response and recovery efforts in 2020 and 2021, including a $20 billion countercyclical support facility and a $9 billion facility specifically for COVID-19 vaccine procurement and vaccination program implementation.
COVID-19 has highlighted the ways that global public goods play an increasingly important role in the world, in both negative and positive ways. It’s increasingly clear that many of the biggest challenges nations face—and the solutions—won’t be restricted to one nation’s borders. The need for regional or global cooperation has never been greater.